Mesoblast Ltd. (MESO)
13.80
-0.48
(-3.36%)
USD |
NASDAQ |
Jun 10, 16:00
13.82
+0.02
(+0.11%)
Pre-Market: 20:00
Mesoblast Market Cap : 1.184B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.184B |
| June 09, 2026 | 1.225B |
| June 08, 2026 | 1.184B |
| June 05, 2026 | 1.197B |
| June 04, 2026 | 1.281B |
| June 03, 2026 | 1.246B |
| June 02, 2026 | 1.246B |
| June 01, 2026 | 1.275B |
| May 29, 2026 | 1.322B |
| May 28, 2026 | 1.267B |
| May 27, 2026 | 1.876B |
| May 26, 2026 | 1.906B |
| May 22, 2026 | 1.945B |
| May 21, 2026 | 1.917B |
| May 20, 2026 | 1.858B |
| May 19, 2026 | 1.862B |
| May 18, 2026 | 1.873B |
| May 15, 2026 | 1.918B |
| May 14, 2026 | 1.929B |
| May 13, 2026 | 1.885B |
| May 12, 2026 | 1.847B |
| May 11, 2026 | 1.856B |
| May 08, 2026 | 1.886B |
| May 07, 2026 | 1.894B |
| May 06, 2026 | 2.023B |
| Date | Value |
|---|---|
| May 05, 2026 | 2.020B |
| May 04, 2026 | 2.047B |
| May 01, 2026 | 2.014B |
| April 30, 2026 | 2.005B |
| April 29, 2026 | 1.990B |
| April 28, 2026 | 1.947B |
| April 27, 2026 | 1.961B |
| April 24, 2026 | 1.984B |
| April 23, 2026 | 1.983B |
| April 22, 2026 | 2.014B |
| April 21, 2026 | 2.070B |
| April 20, 2026 | 2.125B |
| April 17, 2026 | 2.106B |
| April 16, 2026 | 2.059B |
| April 15, 2026 | 2.015B |
| April 14, 2026 | 1.869B |
| April 13, 2026 | 1.881B |
| April 10, 2026 | 1.919B |
| April 09, 2026 | 1.862B |
| April 08, 2026 | 1.781B |
| April 07, 2026 | 1.751B |
| April 06, 2026 | 1.903B |
| April 02, 2026 | 1.895B |
| April 01, 2026 | 2.021B |
| March 31, 2026 | 1.968B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Propanc Biopharma, Inc. | 1.180M |
| Telix Pharmaceuticals Ltd. | 3.154B |
| Amplia Therapeutics Ltd. | 1.677M |
| Immutep Ltd. | -- |
| Fate Therapeutics, Inc. | 217.43M |
Market Cap Related Metrics
| PS Ratio | 27.02 |
| Price to Book Value | 2.360 |
| Price | 13.80 |
| Earnings Yield | -5.34% |